Interleukin-10 peptides and antibodies thereof for inhibiting adverse effects of protozoan infection

US10017569B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10017569-B2
Application numberUS-201615334542-A
CountryUS
Kind codeB2
Filing dateOct 26, 2016
Priority dateJul 13, 2012
Publication dateJul 10, 2018
Grant dateJul 10, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be administered alone or as an animal feed additive to treat gastrointestinal protozoan infection in animals.

First claim

Opening claim text (preview).

What is claimed is: 1. An animal feed additive comprising an isolated antibody that specifically binds to an interleukin-10 peptide, the interleukin-10 peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 20. 2. The animal feed additive of claim 1 , wherein the interleukin-10 peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 7, and SEQ ID NO: 10. 3. The animal feed additive of claim 1 , wherein the isolated antibody is an avian egg antibody. 4. The animal feed additive of claim 3 , wherein the avian egg antibody is concentrated in the egg yolk. 5. The animal feed additive of claim 4 , wherein the egg yolk is dried. 6. The animal feed additive of claim 1 , wherein the antibody is a monoclonal antibody, a synthetic antibody, or a genetically engineered antibody. 7. An isolated antibody that specifically binds to an interleukin-10 peptide, the interleukin-10 peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 20. 8. The isolated antibody of claim 7 , wherein the interleukin-10 peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 7, and SEQ ID NO: 10. 9. A method of generating an antibody, the method comprising administering an interleukin-10 peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 20 to an animal. 10. The method of claim 9 , wherein the interleukin-10 peptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 4, SEQ ID NO: 7, and SEQ ID NO: 10. 11. The method of claim 10 , wherein the generated antibody is concentrated in an egg of an avian animal. 12. The method of claim 11 , wherein the generated antibody is concentrated in an egg yolk of the egg of the avian animal. 13. The method of claim 12 , further comprising isolating the generated antibody from the egg yolk. 14. The method of claim 13 , further comprising drying the egg yolk; and introducing the dried egg yolk into an animal feed. 15. The method of claim 14 , wherein the interleukin-10 peptide is conjugated to a carrier prior to administration. 16. The method of claim 11 , further comprising drying the egg, and introducing the dried egg into an animal feed. 17. A method for treating a gastrointestinal protozoan infection in an animal, the method comprising administering an interleukin-10 peptide or an isolated antibody that specifically binds to an interleukin-10 peptide, the interleukin-10 peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 20. 18. The method of claim 17 , wherein the interleukin-10 peptide or isolated antibody that specifically binds to the interleukin-10 peptide is administered to the animal by injection or oral delivery. 19. The method of claim 17 , wherein the animal is selected from the group consisting of a cow, a pig, a sheep, a fish, a quail, a duck, a turkey, a pheasant and a chicken. 20. The method of claim 17 , wherein the animal is an avian animal selected from the group consisting of a chicken, turkey, duck, pheasant and quail. 21. The method of claim 17 , wherein the protozoa is an Apicomplexa. 22. The method of claim 21 , wherein the protozoa is selected from the group consisting of Cryptosporidium, Eimeria acervulina, Eimeria tenella, Eimeria maxima and Eimeria brunetti. 23. The method of claim 17 , wherein treating the gastrointestinal protozoan infection comprises maintaining growth of the animal. 24. A method for treating a gastrointestinal protozoan infection in an animal, the method comprising administering the isolated antibody that specifically binds to an interleukin-10 peptide, the interleukin-10 peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, and SEQ ID NO: 20. 25. The method of claim 24 , wherein the isolated antibody that specifically binds to the interleukin-10 peptide is administered to the animal by injection or oral delivery. 26. The method of claim 24 , wherein the animal is selected from the group consisting of a cow, a pig, a sheep, a fish, a quail, a duck, a turkey, a pheasant and a chicken. 27. The method of claim 24 , wherein the animal is an avian animal selected from the group consisting of a chicken, turkey, duck, pheasant and quail. 28. The method of claim 24 , wherein the protozoa is an Apicomplexa. 29. The method of claim 28 , wherein the protozoa is selected from the group consisting of Cryptosporidium, Eimeria acervulina, Eimeria tenella, Eimeria maxima and Eimeria brunetti. 30. The method of claim 24 , wherein treating the gastrointestinal protozoan infection comprises maintaining growth of the animal.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10017569B2 cover?
The present disclosure is directed to interleukin-10 (IL-10) peptides and isolated antibodies that specifically bind to the IL-10 peptides. The IL-10 peptides and the isolated antibodies may be administered alone or as an animal feed additive to treat gastrointestinal protozoan infection in animals.
Who is the assignee on this patent?
Wisconsin Alumni Res Found
What technology area does this patent fall under?
Primary CPC classification C07K16/244. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).